Alper Alptekin

Alper Alptekin is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as the Representative Director and President of Organon Japan since June 2021. Prior to this role, Alper held various leadership positions at MSD from March 2007 to June 2021, including Managing Director for Italy and AVP, as well as positions focusing on market access and business unit management for diabetes, cardiology, and women's health. Alper has demonstrated expertise in strategic planning, financial management, and cross-functional collaboration, driving significant sales growth and operational excellence. Educational credentials include a Strategic MBA from Politecnico di Milano and further executive education at Harvard Business School.